QT
DNA icon

Quantbot Technologies’s Ginkgo Bioworks DNA Stock Holding History

Quantbot Technologies’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,012
Closed -$12.3K – 1986
2026
Q1 		$12.3K Sell
2,012
-388
-16% -$3.23K ﹤0.01% 1517
2025
Q4 		$19.9K Buy
+2,400
New +$25.8K ﹤0.01% 1567
2025
Q3 		– Sell
-1,004
Closed -$11.3K – 1815
2025
Q2 		$11.3K Buy
+1,004
New +$7.78K ﹤0.01% 1551
2023
Q2 		– Sell
-1,322
Closed -$70.3K – 1657
2023
Q1 		$70.3K Sell
1,322
-4,618
-78% -$293K 0.01% 1183
2022
Q4 		$402K Buy
+5,940
New +$546K 0.03% 654
2022
Q2 		– Sell
-38
Closed -$6K – 1787
2022
Q1 		$6K Sell
38
-10
-21% -$1.95K ﹤0.01% 1511
2021
Q4 		$15K Buy
+48
New +$22.8K ﹤0.01% 1256

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Quantbot Technologies's DNA Position: Q2 2026 in Review

Quantbot Technologies sold out of Ginkgo Bioworks (DNA) in Q2 2026, closing a stake of 2,012 shares — an estimated $12.3K sold.

Quantbot Technologies first reported a position in DNA in Q4 2021 and held it in 7 quarters. The position peaked at $402K in Q4 2022. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Quantbot Technologies reported no remaining Ginkgo Bioworks position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 2,012 Ginkgo Bioworks shares in Q2 2026, an estimated $12.3K.
  • Quantbot Technologies first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 7 quarters.
  • Quantbot Technologies's Ginkgo Bioworks position peaked at $402K in Q4 2022.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.